Receiver operating characteristic analysis of 939 patients with confirmed CAD and 868 normal subjects indicated that the AhR is a potential marker for objective measurement and evaluation of CAD in addition to other cardiac markers, such as creatine kinase-MB (69). This evidence concerns the gene AHR and coronary artery disorder.